Resmed (RMD) Shares Outstanding (2009 - 2026)

Resmed (RMD) has 18 years of Shares Outstanding (Entity) data on file, last reported at $145.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 0.94% year-over-year to $145.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.3 million (down 0.94% YoY) and the FY2025 annual result came in at $146.7 million, changed 0.21% from the prior year.
• Shares Outstanding (Entity) was little changed at $145.3 million in Q1 2026, from $145.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $147.1 million in Q4 2023 to a low of $145.3 million in Q1 2026.
• A 5-year average of $146.6 million and a median of $146.7 million in 2025 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 0.52% — and 2026, when it slipped 0.94%.
• Tracing RMD's Shares Outstanding (Entity) over 5 years: stood at $146.7 million in 2022, then climbed by 0.29% to $147.1 million in 2023, then dropped by 0.22% to $146.8 million in 2024, then fell by 0.66% to $145.8 million in 2025, then declined by 0.34% to $145.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $145.3 million (Q1 2026), $145.8 million (Q4 2025), and $146.2 million (Q3 2025), per Business Quant data.